PTX
Ann. treating leukemia
Very rare to get such break throughs
This will get some action very soon imo
"The study’s Principal Investigator, Professor Lancet, said, “It is encouraging to see a CRi at this dose level, which brings a total of four complete remissions on the study so far. It was also pleasing to see that this dose level was well tolerated by patients, with no reported dose-limiting toxicities."
- Forums
- ASX - Day Trading
- Morning trading May 10
PTX Ann. treating leukemia Very rare to get such break throughs...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)